UPDATE: Morgan Stanley Reiterates On ResMed Following 1Q15 Earnings Report
October 24, 2014 at 10:12 AM EDT
In a report published Friday, Morgan Stanley analyst Sean Laaman reiterated an Equal-Weight rating on ResMed (NYSE: RMD), and raised ...